Chief Executive Officer
CurrentNeuralert Technologies is revolutionizing stroke detection with a non-invasive, wrist-worn device that provides continuous, real-time monitoring for hospitalized patients. Using proprietary algorithms, the system detects asymmetric arm movements—a key stroke symptom—and sends instant alerts to healthcare providers, reducing detection times from hours to minutes. This enables the care teams to reduce the critical time between the onset of the stroke and the initiation of treatment, thereby improving outcomes for patients.• Began advising Neuralert Founders in February 2020 on healthcare wrist wearables.• Officially joined the team as Chief Technology Officer (CTO) in July 2020.• Stepped in to provide acting-CEO support when Neuralert's original CEO, the late Eric Corkhill, could no longer perform the role due to declining health.• Selected to lead the company forward as CEO in August 2024.• With technology ready, devices manufactured, pilot study already underway, approved pivotal trial, and a Breakthrough Device Designation from the FDA, Neuralert is currently raising a $1-3m "Bridge to Series A".